1. 103 High rates of venous and arterial thrombotic events in POEMS patients. Issue 6 (27th May 2022) Authors: Keddie, Stephen; Sayar, Zara; Weatherill, Anna; Sive, Jonathan; Thomas, Mari; D'Sa, Shirley; Lunn, Michael Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93:Issue 6(2022) Page Start: A43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations. (14th June 2020) Authors: Chavda, Selina J.; Pocock, Rachael; Cheesman, Simon; Lee, Kyung‐Min; Dowling, Emma; Marks, Daniel J. B.; Kyriakou, Charalampia; Lee, Lydia; Sive, Jonathan; Wechalekar, Ashutosh; Rabin, Neil; Yong, Kwee; Popat, Rakesh Journal: British journal of haematology Issue: Volume 190:Number 5(2020) Page Start: e312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial. (21st November 2020) Authors: Camilleri, Marquita; Sive, Jonathan; Wilson, William; Pang, Gavin; Jenner, Richard; Phillips, Elizabeth; Popat, Rakesh; Ramasamy, Karthik; Bygrave, Ceri; Dadaga, Tushhar; Streetly, Matthew; Cavenagh, James; Chapman, Mike; Barrington, Sally; Pike, Lucy; Owen, Roger; Clifton‐Hadley, Laura; Yong, Kwee Journal: British journal of haematology Issue: Volume 192:Number 1(2021) Page Start: e14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome. Issue 3 (5th June 2022) Authors: Khwaja, Jahanzaib; Keh, Ryan; Smyth, Duncan; Lunn, Michael Peter; D'Sa, Shirley; Sive, Jonathan Journal: EJHaem Issue: Volume 3:Issue 3(2022) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of antibody response to SARS‐CoV‐2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy. (29th July 2021) Authors: Chan, Wei Yee; Sanchez, Emilie; Chavda, Selina J.; Lecat, Catherine S. Y.; Ainley, Louise; Xu, Ke; Wisniowski, Brendan; Mahmood, Shameem; Papanikolaou, Xenofon; Kyriakou, Charalampia; Sive, Jonathan; Wechalekar, Ashutosh; Popat, Rakesh; Rabin, Neil; Lee, Lydia; Nastouli, Eleni; Yong, Kwee L. Journal: British journal of haematology Issue: Volume 194:Number 5(2021) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation. (25th November 2020) Authors: Ainley, Louise; Chavda, Selina J.; Counsell, Nicholas; Cheesman, Simon; Newrick, Fiona; Horder, Jackie; Kyriakou, Charalampia; Papanikolaou, Xenofon; Sive, Jonathan; Lee, Lydia; Wechalekar, Ashutosh; Mehta, Atul; Popat, Rakesh; Rabin, Neil; Yong, Kwee Journal: British journal of haematology Issue: Volume 192:Number 3(2021) Page Start: e73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evidence‐based medical treatment of POEMS syndrome. (7th August 2022) Authors: Khwaja, Jahanzaib; D'Sa, Shirley; Lunn, Michael P.; Sive, Jonathan Journal: British journal of haematology Issue: Volume 200:Number 2(2023) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Guidelines on the diagnosis, investigation and initial treatment of myeloma: a British Society for Haematology/UK Myeloma Forum Guideline. (21st March 2021) Authors: Sive, Jonathan; Cuthill, Kirsty; Hunter, Hannah; Kazmi, Majid; Pratt, Guy; Smith, Dean Journal: British journal of haematology Issue: Volume 193:Number 2(2021) Page Start: 245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of COVID-19 on peripheral blood stem cell mobilization for myeloma patients. Issue 12 (15th October 2021) Authors: Camilleri, Marquita; McGrath, Thomas; Wilson, William; Ings, Stuart J.; Horder, Jacqueline; Newrick, Fiona; Sive, Jonathan; Papanikolaou, Xenofon; Popat, Rakesh; Kyriakou, Charalampia; Yong, Kwee; Rabin, Neil Journal: Leukemia & lymphoma Issue: Volume 62:Issue 12(2021) Page Start: 3023 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set. Issue 5 (16th April 2021) Authors: Ziff, Monica; Lawson, Gabrielle; De-Silva, Dunnya; Cheesman, Simon; Kyriakou, Charalampia; Mahmood, Shameem; Papanikolaou, Xenofon; Rabin, Neil; Sachchithananthan, Sajitha; Sive, Jonathan; Wechalekar, Ashutosh; Yong, Kwee; Popat, Rakesh Journal: Leukemia & lymphoma Issue: Volume 62:Issue 5(2021) Page Start: 1243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗